Yoshida Shinya, Sakurai Goro, Yahata Tetsutaro
Department of Rehabilitation, Kanazawa University Hospital, Takaramachi 13-1, Kanazawa, Ishikawa 920-8641 Japan.
Int Cancer Conf J. 2024 Mar 27;13(3):214-217. doi: 10.1007/s13691-024-00663-9. eCollection 2024 Jul.
Cardiac-output response to exercise was evaluated over a 2-year period in hematopoietic stem cell transplant recipients treated with cardiotoxic drugs. During the study period, resting cardiac function was normal; however, the cardiac output response to exercise decreased, and an association with exercise tolerance was observed. Regular assessments of cardiopulmonary function and exercise guidance are vital for patients at high risk of cancer therapy-related cardiac dysfunction, in line with the principles of cardiac oncology rehabilitation.
在接受心脏毒性药物治疗的造血干细胞移植受者中,对其运动时的心输出量反应进行了为期2年的评估。在研究期间,静息心功能正常;然而,运动时的心输出量反应下降,并且观察到与运动耐量有关联。根据心脏肿瘤康复原则,定期评估心肺功能和给予运动指导对于有癌症治疗相关心脏功能障碍高风险的患者至关重要。